How Resolian uses cutting-edge technology to identify impurities in drugs, ensuring their safety and effectiveness.
Our Research
Discover our recent findings, catch up with news, and review in-depth resources.
Single-Day Protein LC-MS Bioanalysis
This paper explains how next-generation trypsins offer faster protein digestion for LC-MS analysis with comparable performance to standard methods.
In Vitro Models for Predicting Transporter-Mediated DDIs
This paper discusses how in vitro studies can be used to predict drug-drug interactions (DDIs) caused by transporters in the body.
A Singlicate Immunogenicity Method to Detect anti-PEG Antibodies
This paper proposes a new method to detect anti-PEG antibodies in serum, potentially improving the safety of PEG-based medications.
Development and Validation of Immunogenicity Assays for ADCs
CASE STUDY – DEVELOPMENT AND VALIDATION OF IMMUNOGENICITY ASSAYS FOR ADCs. Addressing ADC Regulatory Challenges by Providing Validated Assays for Multi-Domain Proteins…
Development and Validation of an Immunogenicity Assay for Detection of Anti-AAV Antibodies
CASE STUDY – ANTI-AAV ANTIBODIES. We are experienced with a wide range of different proteins and therapeutics…
Pharmacokinetics (PK) Urine Analysis
Whereas blood is collected for analysis at a discrete time point, urine is collected over periods of time known as collection intervals…
